Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: rituximab

TNF Blockade for SLE

Martin Aringer, MD, and Maria Dall’Era, MD  |  September 1, 2010

Reckless approach versus missed opportunity?

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:LupusSLESystemic lupus erythematosusTNF BlockadeTreatmenttumor necrosis factor

Mitigate Risk and Increase Success of Lupus Clinical Trials

Andrea Peirce, Peter Lipsky, MD, and Benjamin D. Schwartz, MD, PhD  |  August 1, 2010

Design strategies from a Lupus Research Institute conference

Filed under:ConditionsEthicsProfessional TopicsResearch RheumSystemic Lupus Erythematosus Tagged with:Clinical researchclinical trialsLupusMeetingResearchSLESystemic lupus erythematosus

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  May 1, 2010

Information on New Approvals and Medication Safety

Filed under:Drug Updates Tagged with:ApprovalsDrugsMedicationPipelineSafety

Cochrane Launches Journal Club with RA Article

From the College  |  February 1, 2010

Overview of studies on biologic use kicks off monthly literature review feature

Filed under:Career DevelopmentConditionsEducation & TrainingEducation & TrainingFrom the CollegeProfessional TopicsResearch RheumRheumatoid Arthritis Tagged with:BiologicsCochrane ReviewLiteratureResearch ReviewRheumatoid arthritis

Drug Updates: Information on New Approvals and Medication Safety

Michele B. Kaufman, PharmD, BCGP  |  January 1, 2010

Information on New Approvals and Medication Safety

Filed under:ConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:ApprovalsLansoprazoleOsteoporosisPipeline

Is B a Key to Autoimmune Therapy?: B Cell–targeted Therapies in Autoimmune Disease

Jennifer Anolik, MD, PhD  |  January 1, 2010

A perspective on B cell–targeted therapies in autoimmune disease

Filed under:ConditionsRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:Autoimmuneautoimmune inflammatory diseasesB cellsinflammationRheumatoid arthritisSLESystemic lupus erythematosus

Best Lupus Treatment Still Up for Debate

Kathy Holliman  |  December 1, 2009

Panel looks at decision making for treatment of three high-risk patients

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:azathioprinecyclophosphamideGlucocorticoidsLupus nephritismycophenolate mofetilprednisonerituximab

Research Across the Spectrum

Stephen I. Katz, MD, PhD  |  September 1, 2009

NIAMS director highlights innovative research initiatives

Filed under:Research Rheum Tagged with:ArthritisDiagnosisNIAMSNIHOsteoarthritisResearchRheumatic DiseaseTreatment

Psoriatic Arthritis: From Leeds to the Limelight

Christopher Ritchlin, MD, MPH, and Philip Helliwell, MD, PhD  |  August 1, 2009

Advances in understanding of the disease begin in the 1960s

Filed under:ConditionsOther Rheumatic ConditionsPsoriatic Arthritis Tagged with:DiagnosisGRAPPAPsoriatic Arthritis

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  July 1, 2009

Information on New Approvals and Medication Safety

Filed under:Drug Updates Tagged with:ApprovalsLabeling Changesmycophenolate mofetilNonsteroidal anti-inflammatory drugs (NSAIDs)NSAIDsPipeline

  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences